Raymond James Financial Inc Repligen Corp Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Repligen Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 364,681 shares of RGEN stock, worth $59 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
364,681Holding current value
$59 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
477Shares Held
54.8MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.23 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.03 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$816 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$263 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$230 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.98B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....